Bipolar depression: Treatment options

Canadian Journal of Psychiatry

Volumn 42, Issue SUPPL. 2, 1997, Pages

  Yatham, Lakshmi N ^a   Kusumakar, Vivek ^b   Parikh, Sagar V ^c,d   Haslam, David R S ^b   Matte, Raymond ^e   Sharma, Verinder ^f   Kennedy, Sidney ^d  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^e UNIVERSITÉ DE SHERBROOKE   (Canada)

^f UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Antidepressants; Bipolar depression; Lithium; Mania

Indexed keywords

AMFEBUTAMONE; CARBAMAZEPINE; LITHIUM; MONOAMINE OXIDASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROATE SEMISODIUM;

BIPOLAR DEPRESSION; DRUG EFFICACY; ELECTROCONVULSIVE THERAPY; HUMAN; HYPOMANIA; PHOTOTHERAPY; PSYCHOTHERAPY; REVIEW; SLEEP DEPRIVATION; TREATMENT PLANNING;

ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER; DRUG THERAPY, COMBINATION; ELECTROCONVULSIVE THERAPY; HUMANS; TREATMENT OUTCOME;

EID: 0030823099     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (71)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington (DC): American Psychiatric Association; 1994.
2. Goodwin FK, Jamison KR. Manic-depressive illness. New York: Oxford University Press; 1990.
3. Roy-Byme P, Post RM, Uhde TW, Porcu T, Davis D. The longitudinal course of recurrent affective illness: life chart data from research patients at the NIMH. Acta Psychiatr Scand 1985;71 Suppl 317:1S-34S.
4. Akiskal HS, Walker P, Puzantian VR, King D, Rosenthal TL, Dranon M. Bipolar outcome in the course of depressive illness: phenominologic, familial. and pharmacological predictors. J Affect Disord 1983;5:115-28.
5. Coryell W, Endicott J, Maser JD, Keller MB, Leon AC, Akiskal HS. Long-term stability of polarity distinctions in the affective disorders. Am J Psychiatry 1995;152:385-90.
6. Keller MB, Lavori P, Coryell W, Andreasen NC, Endicott J, Clayton PJ, and others. Differential outcome of pure manic, mixed/cycling, and pure depressive episodes in patients with bipolar illness. JAMA 1986;255:3138-42.
7. Yatham LN, Srisurapanont M, Zis AP, Kusumakar V. Biological distinction between unipolar and bipolar depression: a review of comparative studies. Life Sci 1997. Forthcoming.
8. Kupfer DJ, Weiss BL. Foster FG. Detre TP, Delgado J, McPartland R. Psychomotor activity in affective states. Arch Gen Psychiatry l974;30:765-8.
9. Katz MM. Robins E, Croughan J, Secunda S, Swann A. Behavioural measurement and drug response characteristics of unipolar and bipolar depression. Psychol Med 1982; 12:25-36.
10. Brockington IF, Altman E, Hillier V, Meltzer HY, Nand S. The clinical picture of bipolar affective disorder in its depressed phase: a report from London and Chicago. Br J Psychiatry 1982;141:558-62.
11. Angst J. The course of affective disorders. Psychopathology 1986;19 Suppl 2:47S-52S.
12. Egeland JA, Blumenthaf RL, Nee J, Sharpe L, Endicott J. Reliability and relationship of various ages of onset criteria for major affective disorder. J Affect Disord 1987;12:159-65.
13. Coryell W, Andreasen NC, Endicott J, Keller M. The significance of past mania or hypomania in the course and outcome of major depression. Am J Psychiatry 1987; 144:309-15.
14. Winokur G, Coryell W, Keller M, Endicott J, Akiskal H. A prospective follow-up of patients with bipolar and primary unipolar affective disorder. Arch Gen Psychiatry l983;50:457-65.
15. Goodwin FK, Murphy DL, Dunner DL, Bunney WE Jr. Lithium response in unipolar versus bipolar depression. Am J Psychiatry 1972;15:187-93.
16. Noyes R, Dempsey GM. Blum A, Cavanaugh GL. Lithium treatment in depression. Compr Psychiatry l974;15:187-93.
17. Goldberg JF, Harrow M, Grossman LS. Course and outcome in bipolar affective disorder: a longitudinal follow up study. Am J Psychiatry 1995;152:379-84.
18. Srisurapanont M, Yalham LN, Zis AP. Treatment of acute bipolar depression: a review of the literature. Can J Psychiatry 1995;40:533-44.
19. Wher TA. Goodwin FK. Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatry 1987:144:1403-11.
20. Angst J, Angst K, Baruffol lK, Meinherz-Surbeck R. ECT-induced and drug-induced hypoma-nia. Convuls Ther 1992;8.179-85.
21. Peel M. Induction of mania with selective serolomn re-uptake inhibitors and tricyclic antidepressants. Br J Psychiatry 1994:164:549-50.
22. Kukopulos A, Reginaldi D, Laddomada P, Floris G, Serra G, Tondo L. Course of manic depressive cycle and changes caused by treatments. Pharmokopsychiatr Neuropsychopharmakol 1980;13:156-67.
23. Miklowitz DJ. Psychotherapy in combination with drug treatment for bipolar disorder. J Clin Psychopharmacol 1996;16(2 Suppl 1):56S-66S.
24. Akiskal HS, Akiskal K, Cyclothymic, hyperthymic, and depressive temperaments as subaffective variants of mood disorders. In: Tasman A, Riba MB, editors. American Psychiatric Press review of psychiatry. Washington (DC): American Psychiatric Press; 1992. p 43-62.
25. Mendels J, Frazer A. Intracellular lithium concentration and clinical response: towards a membrane theory of depression. J Psychiatr Res 1973;10:9-18.
26. Goodwin FK, Murphy DL, Bunney WE. Lithium-carbonate treatment in depression and mania: a longitudinal double-blind study. Arch Gen Psychiatry 1969;21:486-96.
27. Greenspan K, Schildkraut JJ, Gordon EK, Baer L, Aronoff MS, Durell J. Catecholamine metabolism in affective disorder-III: MHPG and other catecholamine metabolites in patients treated with lithium carbonate. J Psychiatr Res 1970;7:171-83.
28. Baron M, Gershon ES, Rudy V, Jonas WZ, Buchsbaum M. Lithium carbonate response in depression. Arch Gen Psychiatry 1975;32:1107-11.
29. Mendels J. Lithium in the treatment of depression. Am J Psychiatry 1976;133:373-8.
30. Donnelly EF, Goodwin FK, Waldman IN, Murphy DL, Prediction of antidepressant responses to lithium. Am J Psychiatry 1978;135:552-6.
31. Stokes PE, Shamoian CA, Stoll PM, Patton MJ, Efficacy of lithium as acute treatment of manic-depressive illness. Lancet 1971;1:1319-25.
32. Fieve RR, Platman SR, Plutchik RR. The use of lithium in affective disorders. I: acute endogenous depression. Am J Psychialry 1968;125:487-91.
33. Himmelhoch JM, Fuchs CZ, Symons BJ. A double-blind study of tranylcypromine treatment of major anergic depression. J Nerv Ment Dis 1982;170:628-34.
34. Himmelhoch JM, Thase ME, Mallinger AG, Houck P. Tranylcypromine versus imipramine in anergic bipolar depression. Am J Psychiatry 1991;148:910-6.
35. Thase ME, Mallinger AG, McKnight D, Himmelhoch JM. Treatment of imipramine-resistant recurrent depression. IV: a double-blind crossover study of tranylcypromine for anergic bipolar depression. Am J Psychiatry 1992;149:195-8.
36. Quitkin FM, McGrath P, Liebowitz MR, Stewart J, Howard A. Monoamine oxidase inhibitors in bipolar endogenous depressives. J Clin Psychopharmacol 1981;1:70-3.
37. Baumhachl U, Biziere K, Fischbach R, Geretsegger C, Hebenstreit G, Radmayr E, and others. Efficacy and tolerability of moclobemide compared with imipramine in depressive disorder (DSM-III): an Austrian double-blind, multicentre study. Br J Psychiatry 1989;155 Suppl 6:78S-83S.
38. Conn JB, Collins G, Ashbrook E, Wemicke JF. A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder, Int Clin Psychopharmacol 1989;4:313-22.
39. Simpson SG, DePaulo JR. Fluoxetine treatment of bipolar II depression. J Clin Psychopharmacol 1991;11:52-4.
40. Shopsin B. Bupropion's prophylactic efficacy in bipolar affective illness. J Clin Psychiatry 1983;44:163-9.
41. Sachs GS, Lafer B, Stoll A, Banov M, Thibault AB. Toben M, and others. A double-blind trial of bupropion versus desipramine for bipolar depression. J Clin Psychiatry 1994;55:391-3.
42. Ballenger JC, Post RM. Carbamazepine in manic-depressive illness: a new treatment. Am J Psychiatry 1980;137:782-90.
43. Post RM, Uhde TW, Ballenger JC, Chatterji DC, Greene RF, Bunney WE. Carbamazepine and its -10,11 - epoxide metabolite in plasma and CSF: relationship to antidepressant response. Arch Gen Psychiatry 1983;40:673-6.
44. Post RM, Uhde TW, Roy-Byme PP, Joffe RT Antidepressant effects of Carbamazepine. Am J Psychiatry 1986;143:29-34.
45. Calabrese JR, Delucchi GA. Spectrum of efficacy of valproate in 55 patients with rapid cycling bipolar disorder. Am J Psychiatry 1990;147:431-4.
46. Sachs G. Is divalproex sodium an appropriate initial irealment for bipolar depression. Psychiatric Annals 1996;26(7 Suppl):454S-459S.
47. Calabrese JR. Lamotrigine in treatment-refractory bipolar disorder. In: 149th Annual Meeting of the American Psychiatric Association; 1996 May 4-9; New York, NY. Washington (DC): American Psychiatric Press; 1996. p 15-6.
48. Kusumakar V, Yatham LN. Lamotrigine in treatment of refractory bipolar depression. Psychia-try Res 1997. Forthcoming.
49. Dunner D, Myer SJ, Khan A, Avery D, lshiki D, Pyke R. Adinazolam-a new antidepressant: findings of a placebo-controlled, double-blind study in oulpatients with major depression. J Clin Psychopharmacol 1987;7:170-2.
50. Bocchetta A, Bernardi F, Burrai C, Pedditzi M, Del Zompo M. A double-blind study of L-sulpiride versus amitriptyline in lithium-maintained bipolar depressives. Acta Psychiatr Scand 1993;88:434-9.
51. Post RM, Gemer RH, Carman JS, Gillin GS, Jimerson DC, Goodwin FK. and others. Effects of a dopamine agonist piribedil in depressed patients: relationship of pretreatment homovanillic acid to antidepressant response. Arch Gen Psychiatry 1978;35:609-15.
52. Silverstone T. Response to bromocnptine distinguishes bipolar from unipolar depression [letter]. Lancet 1984;1:903-4.
53. Post RM, Kotin J, Goodwin FK. Effects of sleep deprivation on mood and central amine metabolism in depressed patients. Arch Gen Psychiatry 1976;33:627-32.
54. Wehr TA, Wirz-Justice A, Goodwin FK. Phase advance of the circadian sleep-wake cycle as an antidepressant. Science 1979;206:710-3.
55. Szuba MP, Baxter LR, Fairbanks LA, Guze BH. Schwartz JM. Effects of partial sleep deprivation on the diurnal variation of mood and motor activity in major depression. Biol Psychiatry 1991;30:817-29.
56. Deltito JA, Moline M, Pollak C, Martin LY, Maremmani I. Effects of phototherapy on non-seasonal unipolar and bipolar depressive spectrum disorders. J Affect Disord 1991;23:231-7.
57. Zarate CA Jr, Tohen M, Baldessarini RJ. Clozapine in severe mood disorders. J Clin Psychiatry 1995;56:411-7.
58. Price LH, Chamey DS, Heninger GR. Variability of response to lithium augmentation in refractory depression. Am J Psychiatry 1986;143:1387-92.
59. Kramlinger KG, Post RM, The addition of lithium to carbamazepine: antidepressant efficacy in treatment-resistant depression. Arch Gen Psychiatry 1989:46:794-800.
60. Haykal RF, Akiskal HS Bupropion as a promising approach to rapid cycling bipolar II patients. J Clin Psychiatry 1990;51:450-5.
61. Fogelson DL, Bystritsky A, Pasnau R. Bupropion in the treatment of bipolar disorders: the same old story. J Clin Psychiatry 1992;53:443-6.
62. Folks DG, King LD, Dowdy SB, Petrie WM, Jack RA, Koomen JC, and others. Carbamazepine treatment of selected affectively disordered inpatients. Am J Psychiatry 1982; 139:115-7.
63. Kwamie Y, Persad E, Stancer H. The use of carbamazepine as an adjunctive medication in the treatment of affective disorders: a clinical report. Can J Psychiatry 1984;29:605-8.
64. Greenblatl M, Grosser GH, Wechsler H. A comparative study of selected antidepressant medications and EST. Am J Psychiatry 1962;119:144-53.
65. Bratfos O, Haug JO. Electroconvulsive therapy and antidepressant drugs in manic-depressive disease. Acta Psychiatr Scand 1965;41:588-96.
66. Avery D, Winokur G. The efficacy of electroconvulsive therapy and antidepressants in depression. Biol Psychiatry 1977;12:507-23.
67. Homan S, Lachenbruch PA, Winokur G, Clayton P. An efficacy study of electroconvulsive therapy and antidepressants in the treatment of primary depression. Psychol Med 1982;12:615-24.
68. Zorumski CF, Rutherford JL, Burke WJ, Reich T. ECT in primary and secondary depression. J Clin Psychiatry 1986;47:298-300.
69. Black DW, Winokur G, Nasrallah A. The treatment of depression: electroconvulsive therapy v antidepressants: a naturalistic evaluation of 1.495 patients. Compr Psychiatry 1987; 28:169-82.
70. Altshuler LL, Post RM, Leverich GS, Milkalauskas K, Rosoff A, Ackerman L. Antidepressant induced mania and cycle acceleration: a controversy revisited. Am J Psychiatry 1995; 152:1130-8.
71. Kusumakar V, Yatham LN, Parikh S, Mane R, Sharma V, Silverstone P, and others. Bipolar disorder: a summary of clinical issues and treatment options. CANMAT Monograph. Halifax (NS): 1997. 04. 001. p 28-39.